| abstract |
Compounds of formula I and their pharmaceutically acceptable salts are disclosed. The compound is an inhibitor of plasma kallikrein. Also provided are pharmaceutical compositions comprising at least one compound of the invention, and methods of using the compounds and compositions of the invention to treat and prevent diseases and conditions characterized by undesired plasma kallikrein activity. □ |